Providers' HIV prevention discussions with HIV-seropositive injection drug users

James D. Wilkinson, Wei Zhao, Scott Santibanez, Julia Arnsten, Amy Knowlton, Cynthia A. Gómez, Lisa R. Metsch, Carl Latkin, Amy Knowlton, Karin Tobin, Lisa Metsch, Eduardo Valverde, James Wilkinson, Martina DeVarona, Mary Latka, Dave Vlahov, Phillip Coffin, Marc Gourevitch, Julia H. Arnsten, Robert GernCynthia Gomez, Kelly Knight, Carol Dawson Rose, Starley Shade, Sonja Mackenzie, David Purcell, Yuko Mizuno, Scott Santibanez, Richard Garfein, Ann O'Leary, Lois Eldred, Kathleen Handley

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.

Original languageEnglish (US)
Pages (from-to)699-705
Number of pages7
JournalAIDS and Behavior
Volume10
Issue number6
DOIs
StatePublished - Nov 2006
Externally publishedYes

Fingerprint

Drug Users
HIV
Injections
Primary Health Care
Counseling
Risk Reduction Behavior
Hispanic Americans
Sexual Behavior
Acquired Immunodeficiency Syndrome
Public Health
Communication
Demography
Education

Keywords

  • Acquired immunodeficiency syndrome
  • Human immunodeficiency virus
  • Prevention and control
  • Primary health care
  • Substance abuse, intravenous

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Cite this

Wilkinson, J. D., Zhao, W., Santibanez, S., Arnsten, J., Knowlton, A., Gómez, C. A., ... Handley, K. (2006). Providers' HIV prevention discussions with HIV-seropositive injection drug users. AIDS and Behavior, 10(6), 699-705. https://doi.org/10.1007/s10461-006-9088-4

Providers' HIV prevention discussions with HIV-seropositive injection drug users. / Wilkinson, James D.; Zhao, Wei; Santibanez, Scott; Arnsten, Julia; Knowlton, Amy; Gómez, Cynthia A.; Metsch, Lisa R.; Latkin, Carl; Knowlton, Amy; Tobin, Karin; Metsch, Lisa; Valverde, Eduardo; Wilkinson, James; DeVarona, Martina; Latka, Mary; Vlahov, Dave; Coffin, Phillip; Gourevitch, Marc; Arnsten, Julia H.; Gern, Robert; Gomez, Cynthia; Knight, Kelly; Rose, Carol Dawson; Shade, Starley; Mackenzie, Sonja; Purcell, David; Mizuno, Yuko; Santibanez, Scott; Garfein, Richard; O'Leary, Ann; Eldred, Lois; Handley, Kathleen.

In: AIDS and Behavior, Vol. 10, No. 6, 11.2006, p. 699-705.

Research output: Contribution to journalArticle

Wilkinson, JD, Zhao, W, Santibanez, S, Arnsten, J, Knowlton, A, Gómez, CA, Metsch, LR, Latkin, C, Knowlton, A, Tobin, K, Metsch, L, Valverde, E, Wilkinson, J, DeVarona, M, Latka, M, Vlahov, D, Coffin, P, Gourevitch, M, Arnsten, JH, Gern, R, Gomez, C, Knight, K, Rose, CD, Shade, S, Mackenzie, S, Purcell, D, Mizuno, Y, Santibanez, S, Garfein, R, O'Leary, A, Eldred, L & Handley, K 2006, 'Providers' HIV prevention discussions with HIV-seropositive injection drug users', AIDS and Behavior, vol. 10, no. 6, pp. 699-705. https://doi.org/10.1007/s10461-006-9088-4
Wilkinson JD, Zhao W, Santibanez S, Arnsten J, Knowlton A, Gómez CA et al. Providers' HIV prevention discussions with HIV-seropositive injection drug users. AIDS and Behavior. 2006 Nov;10(6):699-705. https://doi.org/10.1007/s10461-006-9088-4
Wilkinson, James D. ; Zhao, Wei ; Santibanez, Scott ; Arnsten, Julia ; Knowlton, Amy ; Gómez, Cynthia A. ; Metsch, Lisa R. ; Latkin, Carl ; Knowlton, Amy ; Tobin, Karin ; Metsch, Lisa ; Valverde, Eduardo ; Wilkinson, James ; DeVarona, Martina ; Latka, Mary ; Vlahov, Dave ; Coffin, Phillip ; Gourevitch, Marc ; Arnsten, Julia H. ; Gern, Robert ; Gomez, Cynthia ; Knight, Kelly ; Rose, Carol Dawson ; Shade, Starley ; Mackenzie, Sonja ; Purcell, David ; Mizuno, Yuko ; Santibanez, Scott ; Garfein, Richard ; O'Leary, Ann ; Eldred, Lois ; Handley, Kathleen. / Providers' HIV prevention discussions with HIV-seropositive injection drug users. In: AIDS and Behavior. 2006 ; Vol. 10, No. 6. pp. 699-705.
@article{9881fd990191466c90a451408a2922e6,
title = "Providers' HIV prevention discussions with HIV-seropositive injection drug users",
abstract = "Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.",
keywords = "Acquired immunodeficiency syndrome, Human immunodeficiency virus, Prevention and control, Primary health care, Substance abuse, intravenous",
author = "Wilkinson, {James D.} and Wei Zhao and Scott Santibanez and Julia Arnsten and Amy Knowlton and G{\'o}mez, {Cynthia A.} and Metsch, {Lisa R.} and Carl Latkin and Amy Knowlton and Karin Tobin and Lisa Metsch and Eduardo Valverde and James Wilkinson and Martina DeVarona and Mary Latka and Dave Vlahov and Phillip Coffin and Marc Gourevitch and Arnsten, {Julia H.} and Robert Gern and Cynthia Gomez and Kelly Knight and Rose, {Carol Dawson} and Starley Shade and Sonja Mackenzie and David Purcell and Yuko Mizuno and Scott Santibanez and Richard Garfein and Ann O'Leary and Lois Eldred and Kathleen Handley",
year = "2006",
month = "11",
doi = "10.1007/s10461-006-9088-4",
language = "English (US)",
volume = "10",
pages = "699--705",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Providers' HIV prevention discussions with HIV-seropositive injection drug users

AU - Wilkinson, James D.

AU - Zhao, Wei

AU - Santibanez, Scott

AU - Arnsten, Julia

AU - Knowlton, Amy

AU - Gómez, Cynthia A.

AU - Metsch, Lisa R.

AU - Latkin, Carl

AU - Knowlton, Amy

AU - Tobin, Karin

AU - Metsch, Lisa

AU - Valverde, Eduardo

AU - Wilkinson, James

AU - DeVarona, Martina

AU - Latka, Mary

AU - Vlahov, Dave

AU - Coffin, Phillip

AU - Gourevitch, Marc

AU - Arnsten, Julia H.

AU - Gern, Robert

AU - Gomez, Cynthia

AU - Knight, Kelly

AU - Rose, Carol Dawson

AU - Shade, Starley

AU - Mackenzie, Sonja

AU - Purcell, David

AU - Mizuno, Yuko

AU - Santibanez, Scott

AU - Garfein, Richard

AU - O'Leary, Ann

AU - Eldred, Lois

AU - Handley, Kathleen

PY - 2006/11

Y1 - 2006/11

N2 - Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.

AB - Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.

KW - Acquired immunodeficiency syndrome

KW - Human immunodeficiency virus

KW - Prevention and control

KW - Primary health care

KW - Substance abuse, intravenous

UR - http://www.scopus.com/inward/record.url?scp=33750299125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750299125&partnerID=8YFLogxK

U2 - 10.1007/s10461-006-9088-4

DO - 10.1007/s10461-006-9088-4

M3 - Article

C2 - 16639542

AN - SCOPUS:33750299125

VL - 10

SP - 699

EP - 705

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

IS - 6

ER -